Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

25.03 -4.11 (-14.10%)

Official Closing Price Updated: 7:00 PM EDT, May 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

54 55 Next >

Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery? ↗

Today 13:00 EDT

Hims & Hers Health posted a Q1 FY2026 double miss, with an EPS loss of $0.40 and revenue of $608.1 million, sending shares down more than 12% after hours.

Via MarketBeat

Topics Intellectual Property Lawsuit

Why Hims & Hers Health Stock Just Crashed ↗

Today 11:52 EDT

Hims & Hers is unshaken by its earnings miss, with management promising even faster sales growth this year.

Via The Motley Fool

Topics Earnings Lawsuit

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

Today 9:00 EDT

EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates

Today 9:00 EDT

Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors

From MarketNewsUpdates.com

Via GlobeNewswire

Hims & Hers Health (NYSE:HIMS) Misses Q1 2026 Estimates, Shares Drop on GLP-1 Pivot Costs ↗

May 11, 2026

Via Chartmill

Chips Push the S&P 500 to 7,400, Supercycle or the Last Act of a Bubble? ↗

Today 3:04 EDT

Via Chartmill

Topics Stocks

HIMS Q1 Deep Dive: Strategic Pivot in Weight Loss and Margin Pressures Shape Outlook

Today 1:32 EDT

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 mill...

Via StockStory

Topics Artificial Intelligence

Hims & Hers Health Q1 Earnings Call Highlights ↗

Today 0:04 EDT

Hims & Hers Health (NYSE:HIMS) reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company’s weight-loss business is...

Via MarketBeat

Topics Artificial Intelligence Earnings

Hims HIMS Q1 2026 Earnings Call Transcript ↗

May 11, 2026

Hims HIMS Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5%

May 11, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 million. O...

Via StockStory

Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results

May 11, 2026

From Hims & Hers

Via Business Wire

Hims & Hers Health (HIMS) Reports Q1: Everything You Need To Know Ahead Of Earnings

May 09, 2026

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect. Hims & Hers Health met analyst...

Via StockStory

Topics Artificial Intelligence

Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus ↗

May 08, 2026

As Hims & Hers pivots to branded GLP-1s via a Novo Nordisk deal, all eyes are on the company’s May 11 earnings as investors look for sustained subscriber growth.

Via MarketBeat

What the FDA's Latest Proposal Means for Lilly, Novo, and Hims ↗

May 07, 2026

The FDA's latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would also garner indirect benefits.

Via MarketBeat

1 Stock Under $50 with Impressive Fundamentals and 2 We Ignore

May 04, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm

May 01, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

Topics Retirement

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

April 28, 2026

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4% in the afternoon session after the stock's momentum weakened as Amazon.com...

Via StockStory

Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means ↗

April 28, 2026

Via MarketBeat

Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

April 28, 2026

From Hims & Hers

Via Business Wire

SpaceX Goes on $60 Billion AI Buying Spree ↗

April 27, 2026

SpaceX is buying another AI company, but does this mean it can catch up to Google, Anthropic, or OpenAI?

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

April 24, 2026

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 9.6% in the afternoon session after JPMorgan initiated coverage on the comp...

Via StockStory

Topics World Trade

3 Market-Beating Stocks to Research Further

April 24, 2026

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...

Via StockStory

Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗

April 21, 2026

Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026.

Via The Motley Fool

Topics Stocks

A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗

April 21, 2026

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.

Via The Motley Fool

What's Going On With Hims & Hers Shares ↗

April 17, 2026

Shares of Hims & Hers Health Inc. (NASDAQ: HIMS) are rising Friday on the momentum from U.S. drug regulators easing restrictions on peptides.

Via Benzinga

Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies ↗

April 16, 2026

On April 16, 2026, investors monitored an FDA peptide review that could be a boost to Hims & Hers Health.

Via The Motley Fool

Topics Stocks

Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks

April 15, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer...

Via StockStory

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

April 13, 2026

From Hims & Hers

Via Business Wire

Did Hims & Hers Just Become an AI Company? ↗

April 10, 2026

Artificial intelligence could be a big differentiator for Hims & Hers.

Via The Motley Fool

Topics Artificial Intelligence

2 Profitable Stocks with Exciting Potential and 1 We Ignore

April 10, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

54 55 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.